6 April 2018 – Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, today gives further information regarding its final dividend announced on 5 March 2018.
For those shareholders who have previously registered to receive their dividend in US dollars under the Company’s Dividend Currency Election, the dividend will be paid at an exchange rate of $1.40/£1.
For further information, please contact:
- +44 (0)20 7418 8900
- Dan Webster
- George Sellar
- +44 (0)208 004 4218
- Caroline Forde
- Hilary Buchanan
- Robyn Fisher
Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
Craneware is the leader in automated value cycle solutions that help US healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has its headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 250 staff. Craneware’s market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.